Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurobiology of migraine progression
Wanakorn Rattanawong, Alan M. Rapoport, Anan Srikiatkhachorn
Neurobiology of Pain (2022) Vol. 12, pp. 100094-100094
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

The sense of stopping migraine prophylaxis
Linda Al‐Hassany, Hannah Lyons, Deirdre M. Boucherie, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 29
Navigating the Neurobiology of Migraine: From Pathways to Potential Therapies
Masaru Tanaka, Bernadett Tuka, László Vécsei
Cells (2024) Vol. 13, Iss. 13, pp. 1098-1098
Open Access | Times Cited: 13
Atogepant: Mechanism of action, clinical and translational science
Ramesh Boinpally, Mohamad Shebley, Joel M. Trugman
Clinical and Translational Science (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 10
Medication “underuse” headache
Wanakorn Rattanawong, Alan M. Rapoport, Anan Srikiatkhachorn
Cephalalgia (2024) Vol. 44, Iss. 4
Open Access | Times Cited: 9
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study
Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, et al.
Journal of Neurology (2024) Vol. 271, Iss. 5, pp. 2434-2443
Open Access | Times Cited: 8
Impact of multiple treatment cycles with anti-CGRP monoclonal antibodies on migraine course: focus on discontinuation periods. Insights from the multicenter, prospective, I-GRAINE study
Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, et al.
Journal of Neurology (2024) Vol. 271, Iss. 5, pp. 2605-2614
Open Access | Times Cited: 6
Role of ATP in migraine mechanisms: focus on P2X3 receptors
Rashid Giniatullin, Andrea Nistri
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 14
Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study
Piero Barbanti, Gabriella Egeo, Stefania Proietti, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 3, pp. 611-624
Open Access | Times Cited: 5
Medication underuse in real-life practice: the impact of galcanezumab towards achieving very low frequency episodic migraine in a southeast Asian middle-income nation
Wanakorn Rattanawong, Prakit Anukoolwittaya, Akarin Hiransuthikul, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Migraine treatment with CGRP monoclonal antibodies: patient evaluation of a mandatory treatment holiday in Belgium
Ruben De Praeter, Elise Tuerlinckx, Jean Schoenen, et al.
Acta Neurologica Belgica (2025)
Closed Access
Electroacupuncture improves allodynia and central sensitization via modulation of microglial activation associated P2X4R and inflammation in a rat model of migraine
Min Zhou, Fang Pang, Dong-Mei Liao, et al.
Molecular Pain (2024) Vol. 20
Open Access | Times Cited: 4
Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study
Piero Barbanti, Cinzia Aurilia, Paola Torelli, et al.
Journal of Neurology (2025) Vol. 272, Iss. 2
Open Access
The moderating role of cognitive fusion in the relationship between trait and state anger in episodic migraine, chronic migraine and healthy controls
Laura Yunta-Rua, José Luis González, Juan C. Pacho-Hernández, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Searching for the Predictors of Response to BoNT-A in Migraine Using Machine Learning Approaches
Daniele Martinelli, Maria Magdalena Pocora, Roberto De Icco, et al.
Toxins (2023) Vol. 15, Iss. 6, pp. 364-364
Open Access | Times Cited: 10
Treatment patterns and characteristics of headache in patients in Japan: A retrospective cross-sectional and longitudinal analysis of health insurance claims data
Masahito Katsuki, Yasuhiko Matsumori, Taisuke Ichihara, et al.
Cephalalgia (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 3
No Evidence of Cross-Orientation Suppression Differences in Migraine with Aura Compared to Healthy Controls
Louise O’Hare, Choi Lam Wan
Vision (2024) Vol. 8, Iss. 1, pp. 2-2
Open Access | Times Cited: 2
Filling the data gap on CGRP mAb therapy in low- to middle-income countries in Southeast Asia: insights from a real-world study in Thailand
Prakit Anukoolwittaya, Akarin Hiransuthikul, Thanakit Pongpitakmetha, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Developing an Artificial Intelligence-Based Pediatric and Adolescent Migraine Diagnostic Model
Shiori Sasaki, Masahito Katsuki, Junko Kawahara, et al.
Cureus (2023)
Open Access | Times Cited: 4
Breaking the cycle: unraveling the diagnostic, pathophysiological and treatment challenges of refractory migraine
Jennifer Robblee
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 4
Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE—The First Italian Multicenter, Prospective, Real-Life Study
Piero Barbanti, Bianca Orlando, Gabriella Egeo, et al.
Brain Sciences (2024) Vol. 14, Iss. 7, pp. 672-672
Open Access | Times Cited: 1
Impact of 5-HTTLPR of SLC6A4 on migraine susceptibility: A meta-analysis with trial sequential analysis
Amrit Sudershan, Hardeep Kumar, Sandeepa Bailam, et al.
Human Gene (2024) Vol. 42, pp. 201347-201347
Closed Access | Times Cited: 1
Abordagens neurobiológicas na patogênese e tratamento da enxaqueca: uma revisão integrativa
Carlos Wagner Leal Cordeiro Júnior, FABRICIO RICARDO VALERIO, Vanessa Holanda de Souza Ribeiro da Costa, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 2, pp. e68864-e68864
Open Access
To treat or not to treat? Medication underuse headache, a novel reframing
Claire H. Sandoe, Werner J. Becker
Cephalalgia (2024) Vol. 44, Iss. 5
Open Access
Lack of association between TRPV1 gene polymorphisms and risk of migraine chronification: a case-control study and meta-analysis
Martina Giacon, Sarah Cargnin, Marta Allena, et al.
Neurological Sciences (2024)
Open Access
Treatment Patterns, Characteristics, and Probable Acute Medication Overprescription Among Patients With Migraine in Japan: A Retrospective Cross-Sectional and Longitudinal Analysis of Health Insurance Claims Data
Masahito Katsuki, Yasuhiko Matsumori, Taisuke Ichihara, et al.
Cureus (2024)
Open Access
Page 1 - Next Page

Scroll to top